Martin Cronin - Net Worth and Insider Trading

Martin Cronin Net Worth

The estimated net worth of Martin Cronin is at least $10,045 dollars as of 2024-11-13. Martin Cronin is the Director of Gemina Laboratories Ltd and owns about 20,500 shares of Gemina Laboratories Ltd (XCNQ:GLAB) stock worth over $10,045. Details can be seen in Martin Cronin's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Martin Cronin has not made any transactions after 2022-04-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Martin Cronin

To

Martin Cronin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Martin Cronin owns 1 companies in total, including Gemina Laboratories Ltd (XCNQ:GLAB) .

Click here to see the complete history of Martin Cronin’s form 4 insider trades.

Insider Ownership Summary of Martin Cronin

Ticker Comapny Transaction Date Type of Owner
XCNQ:GLAB Gemina Laboratories Ltd 2022-04-21 Director

Martin Cronin Latest Holdings Summary

Martin Cronin currently owns a total of 1 stock. Martin Cronin owns 20,500 shares of Gemina Laboratories Ltd (XCNQ:GLAB) as of April 21, 2022, with a value of $10,045.

Latest Holdings of Martin Cronin

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
XCNQ:GLAB Gemina Laboratories Ltd 2022-04-21 20,500 0.49 10,045

Holding Weightings of Martin Cronin


Martin Cronin Form 4 Trading Tracker

According to the SEC Form 4 filings, Martin Cronin has made a total of 2 transactions in Gemina Laboratories Ltd (XCNQ:GLAB) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Gemina Laboratories Ltd is the acquisition of 4,500 shares on April 21, 2022, which cost Martin Cronin around $2,430.

Insider Trading History of Martin Cronin

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Martin Cronin Trading Performance

GuruFocus tracks the stock performance after each of Martin Cronin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Martin Cronin is 67.9%. GuruFocus also compares Martin Cronin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Martin Cronin within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Martin Cronin's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Martin Cronin

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 25.31 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 29.11 LIMIT LIMIT LIMIT LIMIT LIMIT

Martin Cronin Ownership Network

Ownership Network List of Martin Cronin

No Data

Ownership Network Relation of Martin Cronin

Insider Network Chart

Martin Cronin Owned Company Details

What does Gemina Laboratories Ltd do?

Who are the key executives at Gemina Laboratories Ltd?

Martin Cronin is the Director of Gemina Laboratories Ltd. Other key executives at Gemina Laboratories Ltd include and Director & Director or Senior Officer of 10% Security Holder & Senior Officer John Davies .

Gemina Laboratories Ltd (XCNQ:GLAB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Gemina Laboratories Ltd (XCNQ:GLAB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Gemina Laboratories Ltd (XCNQ:GLAB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Gemina Laboratories Ltd (XCNQ:GLAB)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Gemina Laboratories Ltd Insider Transactions

No Available Data

Martin Cronin Mailing Address

Above is the net worth, insider trading, and ownership report for Martin Cronin. Currently GuruFocus does not have mailing address information for Martin Cronin.